Cointime

Genoox

company

About

Genoox uses the power of the community to make genomic data actionable with a mission to create the largest RWE genomic and clinical dataset

  • 11 - 50

Highlights

Total Funding Amount
$14M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Series B
Last Funding Money Raised
$8M
Industries
Artificial Intelligence,Cloud Data Services,Genetics,Health Care,Health Diagnostics,Machine Learning,Personal Health
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Genoox uses the power of the community to make genomic data actionable, with a mission of creating the largest real world evidence network of genomic and clinical data. Genoox’s cloud-based AI platform connects clinicians, genetic counselors, and healthcare organizations to create a network effect by sharing genetic insights, enabling platform users to make impactful discoveries using the most advanced genomic tools and applications. Genoox is used by over 1,700 health organizations, hospitals and medical facilities in 44 markets across the globe

Amir Trabelsi and Moshe Einhorn founded Genoox in 2014, with its headquarters in Palo Alto in California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$14M
Genoox has raised a total of $14M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2021 Series B $8M 2 — — Detail
May 15, 2018 Series B $6M 1 Triventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Genoox is funded by 2 investors. Infinity Medical and Triventures are the most recent investors.
Investor Name Lead Investor Funding Round
Infinity Medical — Series B
Triventures — Series B
Cointime
Content
Company